Margaret G. Mcglynn - Jun 20, 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Jun 20, 2025
Transactions value $
$181,853
Form type
4
Date filed
6/24/2025, 06:35 PM
Previous filing
Jun 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCGLYNN MARGARET G Director 700 QUINCE ORCHARD ROAD, GAITHERSBURG /s/Mark J. Casey, Attorney-in-Fact 2025-06-24 0001215126

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Stock Option (Right to Buy) Award $182K +28.3K $6.42 28.3K Jun 20, 2025 Common Stock 28.3K $6.42 Direct F3
transaction NVAX Restricted Stock Units Award $0 +18.9K $0.00 18.9K Jun 20, 2025 Common Stock 18.9K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.
F3 One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.